Skip to main content
Premium Trial:

Request an Annual Quote

Peter O Hanley, Ray Cummings, and Denis Burger

Premium

AVI BioPharma announced this week that it has expanded its management team with the addition of two new vice presidents.

The company said that it has named Peter O’Hanley as its senior vice president of clinical development and regulatory affairs, and Ray Cummings as vice president of business development.

According to AVI, O’Hanley was previously vice president of clinical development at Maxygen, before which he was CSO of Preventis. He has also served as vice president and CSO for the anti-infective therapeutic and immunology therapeutic groups at Quintiles, said AVI.

O’Hanley received a PhD and MD from the Medical University of South Carolina, and received his master’s degree in public health from the University of California, Berkeley,

AVI added. AVI said that Cummings was most recently the founder and president of Cummings Consulting. Before his work at this firm, he served as vice president of business development at Aradigm. Prior to this, he was vice president of business development at Celtrix Pharmaceuticals.

AVI said that Cummings holds a master’s degree in business administration from the University of California, Berkeley and an MS in biochemistry and molecular biology from Harvard University.

“Peter and Ray have impressive backgrounds, including negotiating large partnership agreements, designing and implementing global cancer and infectious disease clinical trials, and managing regulatory affairs,” Denis Burger, CEO of AVI, said in a statement.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.